TOP GUIDELINES OF ABBV-744 SAFETY AND SIDE EFFECTS

In Section C, individuals will receive ABBV-744 and oral navitoclax. In Section D, contributors will obtain ABBV-744 and ruxolitinib. Members will acquire treatment till illness progression or maybe the participants are not able to tolerate the study drugs.Celastrol was recognized being a Myb inhibitor that suppressed C/EBPβ action and repressed A